Each year, 20 million people are diagnosed with cancer. Various organs can be affected, and cancer types sometimes differ ...
Researchers showed that small engineered proteins can restore the function of mutated p53 by stabilizing its structure. The ...
Researchers at the University of Illinois Chicago have developed an anti-cancer therapy inspired by bacteria found in cancer ...
Researchers at the University of Illinois Chicago have developed an anti-cancer therapy inspired by bacteria found in cancer ...
Researchers found that loss of HDAC7 disrupted B-cell maturation in mouse models. Restoring HDAC7 suppressed tumor growth, ...
Scientists have uncovered an unexpected way cells can generate cancer-driving proteins—by cutting RNA into shorter, ...
At SGO 2026, Alison Schram, MD, highlighted first-in-class tumor suppressor reactivation and emphasized early NGS testing in ovarian cancer.
Scientists from a German-Swiss consortium have developed miniature antibody-like proteins, called DARPins, that can stabilize and reactivate multiple mutated forms of the p53 tumor suppressor protein ...
New research finds a new strategy for treating a deadly cancer by combining existing drugs to indirectly weaken tumor growth, ...
A Memorial Sloan Kettering Cancer Center study reveals new details about how pancreatic cells carrying oncogenic mutations transition from benign to malignant — shining new light on the ecosystem that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results